![Fillalbin 8-methyl-8-azabicyclo[3.2.1]oct-3-yl 4-hydroxy-3-methoxybenzoate](https://static.cymitquimica.com/products/3D/img/EAA54025.png "Click to enlarge")
Fillalbin 8-methyl-8-azabicyclo[3.2.1]oct-3-yl 4-hydroxy-3-methoxybenzoate
CAS: 4540-25-4
Ref. 3D-EAA54025
| 5mg | 517.00 € | ||
| 10mg | 801.00 € | ||
| 25mg | 1,392.00 € | ||
| 50mg | 2,435.00 € | ||
| 100mg | 4,638.00 € |
Product Information
- Benzoic acid, 4-hydroxy-3-methoxy-, 8-methyl-8-azabicyclo[3.2.1]oct-3-yl ester, endo-
- Benzoic acid, 4-hydroxy-3-methoxy-, (3-endo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl ester
- (3-endo)-8-Methyl-8-azabicyclo[3.2.1]oct-3-yl 4-hydroxy-3-methoxybenzoate
- Vanilloyltropine
- Phyllalbine
Fillalbin 8-methyl-8-azabicyclo[3.2.1]oct-3-yl 4-hydroxy-3-methoxybenzoate is a medicinal compound that has shown potential as an anticancer agent. It works by inhibiting kinases, which are enzymes that play a key role in the growth and spread of cancer cells. Fillalbin has been shown to induce apoptosis, or programmed cell death, in human cancer cells. This analog of kinase inhibitors has also been tested on Chinese hamster ovary cells and found to be effective at inhibiting tumor growth. Fillalbin is excreted in urine and may have potential as a diagnostic tool for cancer detection. Its ability to target specific proteins involved in cancer cell growth makes it a promising candidate for future cancer treatments.
Chemical properties
Technical inquiry about: 3D-EAA54025 Fillalbin 8-methyl-8-azabicyclo[3.2.1]oct-3-yl 4-hydroxy-3-methoxybenzoate
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
